How does LTFF relate to https://www.airiskfund.com/about?
I am confused given the big overlap in people and scope.
I agree these sound like great (though of course high-risk) opportunities, but find myself confused: why are such things not already being funded?
My understanding is that Good Ventures is moving away from some such areas. But what about e.g. the EA Animal Welfare Fund or other EA funders? I don't know much about animal welfare funding, so on face value I am pretty convinced these seem worth funding, but I am worried I am missing something if more sensible/knowledgeable people aren't already funding them. (Though deferring too much to other funders could create too much group-think.)
On Pauses
(As you note much of the value may come from your advocacy making more 'mainstream' policies more palatable, in which case the specifics of Pause itself matter less, but are still good to think about.)
Adverse selection
I am thinking a bit about adverse selection in longtermist grantmaking and how there are pros and cons to having many possible funders. Someone else not funding you could be evidence I/others shouldn’t either, but conversely updating too much on what a small number of grantmakers think could lead to missing lots of great opportunities as a community.
Thanks for writing this up, and congrats on having preliminary promising signs!
I left a bunch of more minor comments in the CEA sheet (thanks for making that public).
Are there any interest groups on the other side of this issue? I suppose budget hawks and fiscal conservatives may try to shoot down any new funding plan, particularly given EU budgetary woes. But otherwise, it seems like a good issue in terms of not making powerful enemies (since the Pharma industry is onside).